Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer
Condition(s): Breast Neoplasms Last Updated: October 26, 2012Withdrawn
Hide Studies Not Seeking New Volunteers
Condition(s): Breast Neoplasms Last Updated: October 26, 2012Withdrawn
Condition(s): Breast Neoplasms Last Updated: March 27, 2012Completed
Condition(s): Healthy Last Updated: January 3, 2013Active, not recruiting
Condition(s): Breast Cancer Last Updated: February 22, 2013Completed
Condition(s): Breast Cancer Last Updated: December 16, 2008Terminated
Condition(s): Breast Neoplasms Last Updated: June 11, 2009Completed
Condition(s): Advanced Breast Cancer Last Updated: October 4, 2012Terminated
Condition(s): Her2 Negative Breast Cancer Patients Last Updated: April 22, 2013Active, not recruiting
Condition(s): Breast Cancer; Estrogen Receptor-Positive Breast Cancer; Breast Cancer, Estrogen Receptor-Positive; ER+ Breast Cancer Last Updated: April 18, 2012Active, not recruiting
Condition(s): Stage IV Non-small Cell Lung Cancer Last Updated: March 4, 2013Recruiting
Condition(s): Breast Cancer Last Updated: October 9, 2012Active, not recruiting
Condition(s): Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer Last Updated: March 26, 2013Active, not recruiting
Condition(s): Breast Cancer Last Updated: June 7, 2012Completed
Condition(s): Breast Carcinoma Last Updated: March 21, 2013Recruiting
Condition(s): Breast Neoplasms Last Updated: May 1, 2013Active, not recruiting
Condition(s): Early Breast Cancer Last Updated: September 25, 2012Terminated
Condition(s): Metastatic Breast Cancer Last Updated: June 29, 2011Completed
Condition(s): Breast Neoplasms Last Updated: February 11, 2010Completed
Condition(s): Breast Neoplasms Last Updated: May 6, 2013Terminated
Condition(s): Breast Cancer Last Updated: April 23, 2013Recruiting